(Q54580773)

1 June 2018

title

Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer. (English)

1 reference

1 June 2018

author name string

Xingyan Liu

1

1 reference

1 June 2018

Zhiwei He

2

1 reference

1 June 2018

Cai-Hong Li

3

1 reference

1 June 2018

Guoliang Huang

4

1 reference

1 June 2018

Congcong Ding

5

1 reference

1 June 2018

Hong Liu

6

1 reference

1 June 2018

publication date

18 June 2011

1 reference

1 June 2018

Pathology Oncology Research

published in

1 reference

1 June 2018

volume

18

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

17-23

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s12253-011-9410-y

exact match

0 references

cites work

The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

What to do with an abnormal PSA test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

STAT proteins: From normal control of cellular events to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Watchful waiting as a treatment option for localized prostate cancer in the PSA era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9410-Y

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

21 January 2018

1 reference

12 December 2020

The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers

1 reference

12 December 2020

MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer

1 reference

12 December 2020

The TNM classification of prostate cancer

1 reference

12 December 2020

[Biological markers of prostate cancer]

1 reference

12 December 2020

Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes

1 reference

12 December 2020

Stats: transcriptional control and biological impact

1 reference

12 December 2020

Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas.

1 reference

12 December 2020

10.1007/S12253-011-9410-Y

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018